Clinical Trial Update: Intraoperative Tumor Margin Identification With ICG Dye Imaging [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating intraoperative identification of tumor margins using indocyanine green (ICG) dye imaging; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Neoplasm
• Malignant Neoplasm

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Benign Neoplasm, Malignant Neoplasm | Phase 2 | Status: RECRUITING